Abbott FDA Warns of Potential False Positives With Abbott SARS-CoV-2 Molecular Tests The agency said the issue could be related to current mixing parameters of the PCR reaction mixture resulting in overflow in wells of the reagent tray. Discarded But Now Needed The New York Times writes that Abbott Laboratories workers discarded SARS-CoV-2 antigen test cards in June and July following decreased testing demand. Abbott Q2 Diagnostics Revenues Rise 63 Percent on COVID-19 Testing Demand The firm said that excluding COVID-19 testing sales, its worldwide diagnostics sales increased 42.5 percent on a reported basis in the second quarter. Abbott Lowers FY21 Guidance as It Sees Sharp Decline in COVID-19 Test Revenue The firm's CEO said that despite the decline, its base business is returning to normal and has "strong momentum." Abbott Q1 Diagnostics Revenues More Than Double on COVID-19 Testing The firm's growth was driven largely by demand for its rapid and laboratory-based COVID-19 tests, which totaled $2.2 billion in revenues for the quarter. Mar 5, 2021 Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections Feb 18, 2021 WHO Finds High Diagnostic Accuracy in Three Classes of MDx Technologies for TB Testing, Resistance Jan 27, 2021 Abbott Q4 Diagnostics Revenues up 111 Percent, FY20 Revenues up 9 Percent Nov 13, 2020 Abbott Enters $5B Credit Agreement Oct 21, 2020 Abbott Q3 Diagnostics Revenues Increase 38 Percent Oct 7, 2020 Abbott ID Now Study Data Confirms Test Sensitivity and Specificity Sep 21, 2020 FDA Revises Emergency Use Authorization for Abbott Point-of-Care SARS-CoV-2 Test Sep 8, 2020 As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza Premium Aug 27, 2020 As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit Jul 21, 2020 AdvaMed Partners With Dx Companies to Create National COVID-19 Supply Registry Jul 17, 2020 Weathering COVID-19 Pandemic, Abbott Beats Analyst Q2 Expectations on Coronavirus Testing Demand Premium Jul 16, 2020 Abbott Q2 Diagnostics Revenues Rise 5 Percent, MDx Revenues Skyrocket Jun 12, 2020 In Brief This Week: Guardant Health, Illumina, Twist Bioscience, Hologic, InCellDx, More Jun 1, 2020 Sema4 Forms Coronavirus Testing Alliance With Connecticut May 28, 2020 AMP SARS-CoV-2 Molecular Dx Survey Shows Supply Chain Issues Hampered Ramp Up of Testing May 26, 2020 Takeda's Alunbrig Gets First-Line FDA Approval With Abbott CDx in ALK-Positive Lung Cancer May 26, 2020 With Low-Cost SARS-CoV-2 Assay, FYR Diagnostics Looks to Bypass Equipment Bottlenecks Premium May 15, 2020 FDA, Abbott Address Accuracy Concerns About SARS-CoV-2 POC MDx Test May 14, 2020 New Study Finds Abbott's ID Now SARS-CoV-2 Test Misses Sensitivity Mark May 12, 2020 Abbott Nabs FDA Emergency Use Authorization for SARS-CoV-2 Test on High-Throughput System Load More Breaking News Beckman Coulter, Invitae Partner to Develop NGS Library Prep Applications Sick Infants Profiled with WGS See Better Diagnosis, More Care Changes UC Santa Cruz Center for Live Cell Genomics Wins $13.5M NIH Grant Genetron Health, Impact Therapeutics Partner for Anti-Cancer Drug, CDx Development Canaccord Genuity Initiates Coverage of Pacific Biosciences With Buy Rating Alternative Genetic Counseling Approach Leads to Higher Patient Satisfaction, Study Suggests The Scan Highly Similar Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News. Gain of Oversight According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research. Lasker for mRNA Vaccine Work The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.